Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial import inner membrane translocase subunit Tim8 A (TIMM8A) is a small mitochondrial intermembrane space chaperone that forms a complex with TIMM13 to facilitate the import and insertion of specific nuclear-encoded hydrophobic proteins into the mitochondrial inner membrane[1][2][3][5]. The TIMM8A-TIMM13 complex is essential for proper mitochondrial protein homeostasis and mitochondrial dynamics, especially in neuronal cells, contributing to the assembly of respiratory chain complexes. Loss-of-function mutations in TIMM8A disrupt this process and cause the severe, X-linked, neurodegenerative Mohr–Tranebjaerg syndrome (deafness-dystonia-optic neuronopathy, DDON), characterized by progressive sensorineural deafness, dystonia, and visual impairment[3][5][6]. TIMM8A is not currently considered a direct therapeutic target (no drugs specifically modulate its activity), but its highly penetrant role in rare genetic disease makes it a biomarker for certain inherited neurodegenerative and mitochondrial disorders[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial import inner membrane translocase subunit Tim8 A (TIMM8A).